QbD Group
    点播网络研讨会

    From R&D to market: IP and regulatory strategy across the product life cycle

    This webinar follows the stages of a product’s life cycle, explaining how structured, science-based development and intellectual property considerations support regulatory alignment and long-term value creation.

    随时观看
    60 分钟
    Regulatory Affairs · Life Sciences
    Chinese

    In collaboration with

    Biovia and Gevers

    What you'll learn

    • How to manage a product strategically throughout its full life cycle
    • The role of Quality by Design in development and regulatory pathways
    • How IP and regulatory strategies interact across product stages
    • Practical insights from real-life industry cases

    向最优秀的人学习

    演讲者

    Anne-Sophie Grell

    Anne-Sophie Grell

    Business Unit Manager RA Medical Devices at QbD Group

    Anne-Sophie is a Regulatory Affairs leader with over two decades of experience in medical physics, diagnostic imaging, and medical device regulation. She supports clients navigating EU MDR, FDA, and international regulatory frameworks.

    Stijn Lagaert

    Stijn Lagaert

    European and Belgian Patent, AttorneyEuropean Patent Litigator and Partner at Gevers

    Stijn Lagaert possesses extensive expertise spanning the biotechnology, pharmaceutical chemistry, plant protection products, fertilizers, and food and feed technologies sectors. He is well-versed in the entire spectrum of patent-related activities, including the meticulous drafting and prosecution of patents. As a European and Belgian Patent Attorney and European Patent Litigator, he brings deep IP knowledge to the life sciences industry.

    Register here

    Is this for you?

    Who should attend?

    This webinar targets R&D-driven organizations and professionals responsible for development strategy, quality by design implementation, and regulatory alignment across the product life cycle. We look forward to welcoming you to this insightful session!

    Keep watching

    More webinars

    From Strategy to First-in-Human: A Practical Roadmap for Biotech Development 点播网络研讨会

    From Strategy to First-in-Human: A Practical Roadmap for Biotech Development

    Regulatory Affairs2026年3月18日

    Early-stage biotech teams often struggle to translate scientific innovation into first-in-human readiness. This webinar provides practical guidance to help teams build a clear, scalable development pathway that aligns regulatory strategy, CMC, quality, and clinical planning. Reducing risk, avoiding delays, and staying inspection-ready without overbuilding internal structures.

    立即观看

    Turn Your MedTech Innovation into Reality

    Regulatory, quality, and clinical support for MedTech startups and scale-ups bringing innovative devices to market.

    Emerging MedTech

    我们使用 Cookie 来改善您的体验

    我们使用必要的 Cookie 来保证网站功能,以及可选的分析 Cookie 来改善我们的服务。 阅读我们的 隐私政策Cookie 政策.